116 related articles for article (PubMed ID: 2629757)
1. [Epidemiologic study of HIV serology in blood donors from 5 departments in northeastern France (1985-1989)].
Aymard JP; Janot C; Contal P; Linel C; Monange G; Streiff F
Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):421-9. PubMed ID: 2629757
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiologic study of HIV serology among blood donors in the north-eastern region of France].
Fabre G; Joussemet M; Vincent M
Rev Fr Transfus Hemobiol; 1990 Jun; 33(3):223-5. PubMed ID: 2206169
[No Abstract] [Full Text] [Related]
4. [2-year anti-HIV donor screening in the Central Laboratory of the Swiss Red Cross Blood Transfusion Service].
Lang O; Bachmann P; Baumgartner C; Bütler R
Schweiz Med Wochenschr; 1988 Apr; 118(15):547-53. PubMed ID: 3375791
[TBL] [Abstract][Full Text] [Related]
5. [HIV seropositivity in blood donors from 1990 to 1992: prevalence, estimation of residual risk of transfusion-related infections and epidemiology].
Couroucé AM
Rev Fr Transfus Hemobiol; 1993 Jul; 36(4):327-37. PubMed ID: 8357445
[TBL] [Abstract][Full Text] [Related]
6. Methodologic approaches to surveillance of HIV infection among blood donors.
Petersen LR; Dodd R; Dondero TJ
Public Health Rep; 1990; 105(2):153-7. PubMed ID: 2108461
[TBL] [Abstract][Full Text] [Related]
7. [HIV seropositivity in blood donations: prevalence, residual risk and epidemiology. The "Retrovirus" Work Group of the French Society of Blood Transfusion].
Couroucé AM
Transfus Clin Biol; 1995; 2(5):357-63. PubMed ID: 8581178
[TBL] [Abstract][Full Text] [Related]
8. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus antibodies in sera of Australian blood donors: 1985-1990.
Kaldor J; Whyte B; Archer G; Hay J; Keller A; Kennedy T; Mackenzie I; Pembrey R; Way B; Whyte G
Med J Aust; 1991 Sep; 155(5):297-300. PubMed ID: 1895970
[TBL] [Abstract][Full Text] [Related]
10. [Four year management of HIV serology at the National Center of Blood Transfusion in Conakry].
Loua A; Magassouba FB; Camara M; Haba NG; Balde AM
Bull Soc Pathol Exot; 2004 May; 97(2):139-41. PubMed ID: 15255362
[TBL] [Abstract][Full Text] [Related]
11. HIV seroprevalence in healthy blood donors in northeastern Zaire.
Fischer PR; Toko RM
Int J STD AIDS; 1995; 6(4):284-6. PubMed ID: 7548293
[TBL] [Abstract][Full Text] [Related]
12. HIV seroprevalence among healthy blood donors in northeastern Zaire.
Fischer PR; Horton GL; Knight P; Lusi KM
Int J STD AIDS; 1991; 2(1):52-3. PubMed ID: 2036462
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus: Thailand.
Nuchprayoon C; Tanprasert S; Chumnijarakij T; Thanomchat S; O'Prasert B; Adulwijit S
Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):98-103. PubMed ID: 8525427
[TBL] [Abstract][Full Text] [Related]
14. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and epidemiologic features of subjects found to be infected with HIV when donating blood. CTS of the "Retrovirus" Study Group of the Société Nationale de Transfusion Sanguine].
Couroucé AM; Baudelot J; Elghouzzi MH; Gueguen M; Janot C; Lemaire JM; Maniez M; Mesnier F; Noël L; North ML
Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):431-8. PubMed ID: 2285451
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
McFarland W; Mvere D; Katzenstein D
AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
[TBL] [Abstract][Full Text] [Related]
17. Trends in human immunodeficiency virus seroprevalence in blood donors in northern Pakistan.
Ghani E; Rathore MA; Khan SA
Public Health; 2016 Feb; 131():71-4. PubMed ID: 26652710
[TBL] [Abstract][Full Text] [Related]
18. HIV-related risk factors of blood donors in northern Thailand before and after knowing HIV test results.
Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
Int J Epidemiol; 1997 Apr; 26(2):408-13. PubMed ID: 9169178
[TBL] [Abstract][Full Text] [Related]
19. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
[TBL] [Abstract][Full Text] [Related]
20. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.
Vučetić D; Kecman G; Ilić V; Balint B
Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
